ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625507 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625507; 2) Community: the network communities that were significantly associated with the response to NSC 625507; 3) Molecule: the relationships between components within communities and NSC 625507; 4) MDR: the compounds that were significantly associated with the NSC 625507.

NSC Compound Enrichment Correlation
NSC 711733 Null 0.0122129861493296 0.57538684
NSC 718730 Null 0.0122129861493296 0.47659648
NSC 758662 Lovastatin [USAN] 0.0122129861493296 -0.13975044
NSC 760979 Null 0.0122129861493296 0.30428126
NSC 11668 N4,N6-bis(3-chlorophenyl)-1-methyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine 0.0131142867047947 0.36049086
NSC 139021 1-(2-Thiazolylazo)-2-naphthol 0.0131142867047947 0.50723819
NSC 145219 Null 0.0131142867047947 0.40502885
NSC 146604 FUR 0.0131142867047947 0.21879834
NSC 212446 Null 0.0131142867047947 0.47979103
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0131142867047947 0.63700083
Total:151  Current:68    [First] [Prev] [Next] [Last]